Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anamorelin after radical surgery for upper gastric and esophagogastric junction cancer (phase II exploratory RCT)
jRCTs031230646Phase 2Recruiting
- Sponsor
- Clinical Research Initiation-Fund (of Chiba University Hospital)
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of anamorelin in gastric cancer (GC) and esophagogastric junction cancer (2 arms), sponsored by Clinical Research Initiation-Fund (of Chiba University Hospital). Started Jul 2024; status: recruiting.
02
Drugs
anamorelin
03
Conditions
gastric cancer (GC)esophagogastric junction cancer
Beyond the preview
Go deeper on jRCTs031230646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230646.